RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2024 -- It is with deep sadness that Pappas Capital announces the passing of Dr. Ernest Mario, Senior Venture Partner and one of the founders...
Liquidia begins testing flu vaccine
News | 10. 06. 2010
Liquidia Technologies
Liquidia Technologies has started early clinical testing of its first vaccine developed using nanotechnology.
